| Announce Date | 12/03/2025 |
| EPS Normalized Actual | $-0.14 (Miss by $-0.06) |
| EPS GAAP Actual | $-0.14 (Miss by $-0.06) |
| Revenue Actual | $0.120879B |
| Revenue Surprise | Beat by $120.879M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.0993 |
| EPS GAAP Estimate | $-0.0993 |
| Revenue Estimate | $0.1317267B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2028 | 0 | INF | 0 | 0 | 0 |
| Sep 2027 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.83 | -0.25 | 0.120879B | 0.83% | -22.75M |
| FQ3 2025 (Sep 2025) | -0.25 | 0.42 | 0.138142B | 5.59% | 1.03M |
| FQ2 2025 (Jun 2025) | -0.51 | -0.91 | 0.130683B | 19.05% | -26.5M |
| FQ1 2025 (Mar 2025) | -0.44 | -0.58 | 0.124323B | 4.25% | -18.51M |
| FQ4 2024 (Dec 2024) | -1.1 | -0.29 | 0.119876B | -13.03% | -5.89M |
| FQ3 2024 (Sep 2024) | -1.12 | -1.12 | 0.130417B | -7.92% | 130.42M |
| FQ2 2024 (Jun 2024) | -1 | -1 | 0.105786B | -48.86% | 105.79M |
| FQ1 2024 (Mar 2024) | -1.86 | -1.86 | 0.119035B | -27.24% | 119.04M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.0993
Consensus Revenue Estimates
0.1317267B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | -0.003552 | -- | -0.00364096 | -0.00346015 | 1 |
| FQ1 2027 (Mar 2027) | -0.025216 | -- | -0.02536036 | -0.02507164 | 1 |
| FQ4 2026 (Dec 2026) | -0.054789 | -1414.9 | -0.05510267 | -0.05447533 | 1 |
| FQ2 2026 (Jun 2026) | -0.0578 | -782.35 | -0.05940857 | -0.05596156 | 1 |
| FQ1 2026 (Mar 2026) | -0.0993 | -343.1 | -0.10206 | -0.09614157 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 0.14B | -- | 0.14B | 0.14B | 2 |
| FQ1 2027 (Mar 2027) | 0.14B | -- | 0.14B | 0.14B | 1 |
| FQ4 2026 (Dec 2026) | 0.13B | 9.78 | 0.13B | 0.13B | 1 |
| FQ2 2026 (Jun 2026) | 0.13B | 1.33 | 0.13B | 0.14B | 1 |
| FQ1 2026 (Mar 2026) | 0.13B | 5.62 | 0.13B | 0.13B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | -0.58 | -0.83 | -0.25 | 30.12% |
| FQ3 2025 (Sep 2025) | -0.67 | -0.25 | 0.42 | -168% |
| FQ2 2025 (Jun 2025) | 0.4 | -0.51 | -0.91 | 178.43% |
| FQ1 2025 (Mar 2025) | 0.14 | -0.44 | -0.58 | 131.82% |
| FQ4 2024 (Dec 2024) | -0.81 | -1.1 | -0.29 | 26.36% |
| FQ3 2024 (Sep 2024) | -1.12 | -1.12 | 100% | |
| FQ2 2024 (Jun 2024) | -1 | -1 | 100% | |
| FQ1 2024 (Mar 2024) | -1.86 | -1.86 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0.14B | $0.12B | $-22.75M | -18.82% |
| FQ3 2025 (Sep 2025) | $0.14B | $0.14B | $1.03M | 0.75% |
| FQ2 2025 (Jun 2025) | $0.16B | $0.13B | $-26.5M | -20.28% |
| FQ1 2025 (Mar 2025) | $0.14B | $0.12B | $-18.51M | -14.89% |
| FQ4 2024 (Dec 2024) | $0.13B | $0.12B | $-5.89M | -4.91% |
| FQ3 2024 (Sep 2024) | $0B | $0.13B | $130.42M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.11B | $105.79M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.12B | $119.04M | 100% |